Additionally, the proto‐oncogene MYCN was upregulated together with SOX2 and YAP1, both markers for stem cell self‐renewal, reprogramming and homeostasis, as well as mechanistically promoting proliferation, survival, invasion/metastasis, cancer stemness and drug resistance [20, 21]. This evidence concerns the gene MYCN and cancer.